A Randomized Controlled Trial of OPT-302, a VEGF-C/D Inhibitor for Neovascular Age-Related Macular Degeneration

Jackson, TL; Slakter, J; Buyse, M; Wang, K; Dugel, PU; Wykoff, CC; Boyer, DS; Gerometta, M; Baldwin, ME; Price, CF

Jackson, TL (通讯作者)，Kings Coll London, Kings Coll Hosp, Ophthalmol Dept, London SE5 9RS, England.

OPHTHALMOLOGY, 2023; 130 (6): 588

Abstract

Purpose: Neovascular (wet) age-related macular degeneration (nAMD) is driven by VEGFs A, C, and D, which promote angiogenesis and vascular permeabilit......

Full Text Link


Links

期刊讨论 | 中国SCI论文 | 期刊主页 | 投稿经验 | 杂志官网 | 投稿链接 | 作者需知 | PMC链接 | Pubmed全文检索